Sleep aids, including melatonin, are commonly used in children and adolescents, yet few studies have examined family- and ...

The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by type 1 diabetes.

Intraoperative reirradiation in combination with a second breast-conserving surgery is safe and well tolerated in patients ...

Patients with HIV infection who receive a liver transplant may face a similar risk of developing new cancers as those without ...

Patients with chronic kidney disease are often taken off RAS inhibitors after declines in kidney function, but the risks may ...

Researchers conducted a retrospective cross-sectional analysis of patients diagnosed with de novo metastatic breast cancer to evaluate presentation and treatment differences across three main subtypes ...

Individuals who only use heated tobacco products do not have a lower risk for type 2 diabetes than those who only smoke ...

There was a study published from Sweden in which they looked at the different subtypes of type 2 diabetes in a population ...

The EMA has recommended label expansions for Inaqovi, Opdivo, and Venclyxto, broadening treatment options in AML, Hodgkin lymphoma, and CLL.

The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in children aged 6 years or older who require systemic therapy.

Critics say the government does not give effective strategies enough time or money to scale up and deliver robust outcomes.